Cargando…
Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
The influenza pandemic of 2009 demonstrated the inability of the established global capacity for egg-based vaccine production technology to provide sufficient vaccine for the population in a timely fashion. Several alternative technologies for developing influenza vaccines have been proposed, among...
Autor principal: | López-Macías, Constantino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426084/ https://www.ncbi.nlm.nih.gov/pubmed/22330956 http://dx.doi.org/10.4161/hv.18757 |
Ejemplares similares
-
Zika virus-like particle (VLP) based vaccine
por: Boigard, Hélène, et al.
Publicado: (2017) -
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023) -
The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017) -
Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021) -
Process development for pandemic influenza VLP vaccine production using a baculovirus expression system
por: Lai, Chia-Chun, et al.
Publicado: (2019)